RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma.
Han ZhuoJunwei TangFeihong ZhangZheng-Gang XuDongwei SunYue TengZhongming TanPublished in: Journal of clinical and translational hepatology (2022)
RP11-40C6.2 is an HBV infection-related lncRNA that exerts its oncogenic effects by targeting the Hippo signaling pathway.